USPTO serial 97384728
GORDIAN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- REID, MONICA R
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GORDIAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Francisco, CA
San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tracy-Gene G. Durkin
Tracy-Gene G. Durkin STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.1100 NEW YORK AVENUE, N.W.WASHINGTON, DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer | ACTIVE | — |
| 042 | Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics | ACTIVE | — |
| 044 | Providing medical information on aging and complex multigenic diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gordian Biotechnology
- Other trademarks owned by Gordian Biotechnology
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GORDIAN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 18, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 18, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 15, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 20, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 20, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 31, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2022 | NWAP | NEW APPLICATION ENTERED | — |